Kavanaugh A - Search Results

1

Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments.

Bieber J, Kavanaugh A. Bieber J, et al. Among authors: kavanaugh a. Rheum Dis Clin North Am. 2004 May;30(2):257-70, v. doi: 10.1016/j.rdc.2004.01.003. Rheum Dis Clin North Am. 2004. PMID: 15172039 Review.

2

Combination cytokine therapy: the next generation of rheumatoid arthritis therapy?

Kavanaugh A. Kavanaugh A. Arthritis Rheum. 2002 Feb;47(1):87-92. doi: 10.1002/art1.10158. Arthritis Rheum. 2002. PMID: 11932883 Free article. Review. No abstract available.

3

Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.

Kavanaugh A, Genovese M, Baughman J, Kivitz A, Bulpitt K, Olsen N, Weisman M, Matteson E, Furst D, van Vollenhoven R, Anderson J, Cohen S, Wei N, Meijerink J, Jacobs C, Mocci S. Kavanaugh A, et al. J Rheumatol. 2003 Mar;30(3):449-54. J Rheumatol. 2003. PMID: 12610799 Clinical Trial.

4

Secondary immune deficiencies associated with biological therapeutics.

Lee SJ, Yedla P, Kavanaugh A. Lee SJ, et al. Among authors: kavanaugh a. Curr Allergy Asthma Rep. 2003 Sep;3(5):389-95. doi: 10.1007/s11882-003-0072-z. Curr Allergy Asthma Rep. 2003. PMID: 12906774 Review.

5

Pharmacological treatment of established rheumatoid arthritis.

Lee SJ, Kavanaugh A. Lee SJ, et al. Among authors: kavanaugh a. Best Pract Res Clin Rheumatol. 2003 Oct;17(5):811-29. doi: 10.1016/s1521-6942(03)00048-2. Best Pract Res Clin Rheumatol. 2003. PMID: 12915159 Review.

6

Rheumatic disease in the elderly: rheumatoid arthritis.

Tutuncu Z, Kavanaugh A. Tutuncu Z, et al. Among authors: kavanaugh a. Clin Geriatr Med. 2005 Aug;21(3):513-25, vi. doi: 10.1016/j.cger.2005.02.009. Clin Geriatr Med. 2005. PMID: 15911204 Review.

7

Novel therapies for rheumatoid arthritis.

Chang J, Kavanaugh A. Chang J, et al. Among authors: kavanaugh a. Pathophysiology. 2005 Oct;12(3):217-25. doi: 10.1016/j.pathophys.2005.07.008. Pathophysiology. 2005. PMID: 16099629 Free article.

8

Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents.

Tutuncu Z, Kavanaugh A, Zvaifler N, Corr M, Deutsch R, Boyle D. Tutuncu Z, et al. Among authors: kavanaugh a. Arthritis Rheum. 2005 Sep;52(9):2693-6. doi: 10.1002/art.21266. Arthritis Rheum. 2005. PMID: 16142749 Free article.

9

Adverse reactions to biologic agents: focus on autoimmune disease therapies.

Lee SJ, Kavanaugh A. Lee SJ, et al. Among authors: kavanaugh a. J Allergy Clin Immunol. 2005 Oct;116(4):900-5. doi: 10.1016/j.jaci.2005.03.028. J Allergy Clin Immunol. 2005. PMID: 16210067 Review.

10

Factors affecting rheumatoid arthritis patients' decisions to participate in clinical trials.

Lee SJ, Lenert L, Weisman S, Kavanaugh A. Lee SJ, et al. Among authors: kavanaugh a. J Rheumatol. 2005 Dec;32(12):2317-25. J Rheumatol. 2005. PMID: 16331756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters